Repurposing Niacin as Antiplatelet Drug?

被引：0
|
作者：
Mangoni, Arduino A. [1 ,2 ]
机构：
[1] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia
[2] Flinders Med Ctr, Bedford Pk, SA 5042, Australia
来源：
CURRENT CLINICAL PHARMACOLOGY | 2016年 / 11卷 / 01期
关键词：
D O I：
10.2174/157488471101160204113351
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2 / +
页数：2
相关论文
共 50 条
  • [21] Antiplatelet Drug Resistance
    包承鑫
    血栓与止血学, 2008, (02) : 51 - 52
  • [22] ASPIRIN AS AN ANTIPLATELET DRUG
    PATRONO, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (18): : 1287 - 1294
  • [23] Antiplatelet drug interactions
    Mackenzie, I. S.
    Coughtrie, M. W. H.
    MacDonald, T. M.
    Wei, L.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (06) : 516 - 529
  • [24] Drug repurposing in status epilepticus
    Walker, Matthew C.
    EPILEPSY & BEHAVIOR, 2024, 161
  • [25] Computational methods for drug repurposing
    Sanseau, Philippe
    Koehler, Jacob
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 301 - 302
  • [26] Drug repurposing for cancer therapy
    Xia, Ying
    Sun, Ming
    Huang, Hai
    Jin, Wei-Lin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [27] Drug Repurposing and the Medicinal Chemist
    Aube, Jeffrey
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (06): : 442 - 444
  • [28] Drug repurposing for Ebola virus
    不详
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (290)
  • [29] Drug repurposing with network reinforcement
    Nam, Yonghyun
    Kim, Myungjun
    Chang, Hang-Seok
    Shin, Hyunjung
    BMC BIOINFORMATICS, 2019, 20 (Suppl 13)
  • [30] Drug Repurposing for Cancer Therapies
    Xavier, Cristina P. R.
    Palmeira, Andreia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
12345